Osage University Partners — Full Portfolio

Immvention Therapeutics develops first-in-class BACH1 inhibitors intended as an oral therapy for patients with sickle cell disease and other conditions.

BiotechDigital HealthChapel Hill, US

Jenny Ting(Director and Co-founder)Anil Goyal(CEO and Director)

Co-investorsDelin VenturesHatteras Venture Partners

Addition Therapeutics is a biotechnology company developing therapeutics, led by a scientific and clinical team.

BiotechHealthtechSouth San Francisco, US

Kathleen Collins(Director)inLawrence Kong(Executive Officer)inRon Park(President & CEO)inFrancine Gregoire(Chief Scientific Officer)inPriya Parameswaran(Chief Business Officer)in

BoardJayson Punwani(Director)

Co-investorsSR One Capital ManagementAbingworthPivotal Life Sciences

Arrakis Therapeutics develops RNA-targeted small-molecule (rSM) medicines, working independently and with partners to create drug candidates aimed at the root causes of disease.

AI & Machine LearningBiotechDeep TechHealthtechCambridge, US

Michael Gilman(Executive Officer, Director)inMark DeLong(CEO)inDavid Neafus(Executive Officer)inRussell C. Petter(Executive Officer)

BoardColleen Cuffaro(Director)inAlan E. Walts(Director)in

Co-investorsCanaan PartnersPfizer VenturesAdvent Life SciencesNextech InvestOUP (Osage University Partners)Pfizer Venture Investments+1 more

AssetWatch provides cloud-based asset monitoring software and sensor technology to help manufacturing and industrial facilities prevent unplanned equipment downtime.

Advanced ManufacturingEnterprise SoftwareIoTSaaSWesterville, US

William Zell(Executive Officer, Director)William Ruff(Executive Officer)inRobert Lee(Director)inTad Dritz(VP of Development)inJeff Haskett(COO)inBrian Graham(Executive Officer, Director)in

Co-investorsCerity Partners VenturesG2 Venture PartnersHarmonic Growth PartnersJobsOhio VenturesMonte Carlo CapitalOUP (Osage University Partners)+4 more

BiotechAnn Arbor, US

Julia C. Owens(Executive Officer, Director)

BoardCarol Gallagher(Director)James Topper(Director)William Harrington(Director)Randall Whitcomb(Director)

Co-investors5AM VenturesFrazier Life SciencesThird Rock Ventures

BiotechSouth San Francisco, US

Wendye Robbins(Executive Officer, Director)

BoardLuke Evnin(Director)inCameron Wheeler(Director)Peter van Vlasselaer(Director)Elaine Jones(Director)William Slattery(Director)

Co-investorsBay City CapitalOUP (Osage University Partners)Pfizer Venture Investments+ND CapitalDeerfield Management CompanyMPM BioImpact

Brimstone develops co-production processes to manufacture cement, steel, aluminum, and other critical minerals from a single feedstock in an integrated facility.

Advanced ManufacturingCircular EconomyCleantechConstruction TechNew MaterialsOakland, US

Cody Finke(CEO)inHugo LeandriinCody Finke, Ph.D.(Founder)in

Co-investorsAccelr8Collaborative FundCreative Destruction Lab (CDL)DCVC (Data Collective)Fifth WallGVP Climate+7 more

Clarifai developed AI inference technology and compute orchestration software for running and optimizing machine learning models at scale.

AI & Machine LearningCloud ComputingData & InfrastructureNew York, US

Matthew Zeiler(Executive Officer, Director)in

BoardAlbert Wenger(Director)in

Co-investorsBright Pixel CapitalCorazon CapitalGV (Google Ventures)Lux CapitalMenlo VenturesNew Enterprise Associates (NEA)+12 more

BiotechBurlingame, US

Mark Rolfe(Executive Officer)Laura Shawver(Executive Officer, Director)Timothy Smith(Executive Officer)

BoardAlfred Scheidegger(Director)inPeter Thompson(Director)Carol Gallagher(Director)

Co-investorsAstellas Venture Management LLCNew Enterprise Associates (NEA)Nextech Invest5AM VenturesClarus VenturesOrbiMed+1 more

Crozet, US

Randy Caldejon(Chairman, Chief Executive Officer and President)Erik Breuhaus(Chief Financial Officer)Peter Shaw(Vice President)in

BoardMatthew Swartz(Director)

DualEntry is an AI-native enterprise resource planning (ERP) platform designed to replace legacy accounting systems for mid-market to enterprise businesses.

AI & Machine LearningEnterprise SoftwareFintechSaaSNew York, US

Santiago Nestares(Co-founder)inBenedict Dohmen(Founder)in

Co-investorsContraryKhosla VenturesLightspeed Venture PartnersGV (Google Ventures)Carya Venture PartnersLudlow Ventures+9 more

Everactive develops ultra-low power, self-powered systems-on-chip (SoCs) for Ambient IoT devices that sense, process, and wirelessly transmit data using harvested environmental energy instead of batteries.

HardwareIoTSemiconductorsSan Jose, US

Benton Calhoun(Executive Officer, Director)inDavid Wentzloff(Executive Officer, Director)Brendan R Richardson(Executive Officer, Director)

BoardGeorge Kastendike(Director)Greg Papadopoulos(Director)Jack Busch(Director)

Co-investorsBlue Bear Capital PartnersNew Enterprise Associates (NEA)OUP (Osage University Partners)ABB Technology Ventures

Hack VC is a venture capital firm that invests in early-stage web3, crypto, and AI startups, with focus areas including decentralized infrastructure, DeFi, privacy-preserving technologies, and cryptography.

AI & Machine LearningCrypto & Web3Fintech

Alex(Co-founder & Managing Partner)Ed(Co-founder & Special Advisor)

Co-investorsEvolution VC PartnersNimble PartnersSerafundWeb3com VenturesBrighteye VenturesMarathon Venture Capital+3 more

BiotechPhiladelphia, US

Philip R. Johnson, M.D.(Executive Officer, Director)inDora Mitchell(Executive Officer)Lori Forrest(Executive Officer)Leon Moulder, Jr.(Director)Benjamin Lund(Director)

BoardTomas Kiselak(Director)

Co-investorsOUP (Osage University Partners)Pfizer Venture InvestmentsAgent CapitalBain Capital Life SciencesLongwood FundPfizer Ventures+2 more

BiotechSan Diego, US

Kevin Forrest, Ph.D.(Executive Officer, Director)

BoardClare Ozawa, Ph.D.(Director)Beth Seidenberg, M.D.(Director)

Co-investorsWestlake Village BioPartnersVersant Ventures

Vertically-integrated machine learning platform for healthcare powering transition to value-based care with predictive analytics.

Co-investorsMindset VentureOUP (Osage University Partners)

Kymeta develops flat-panel satellite antennas and connectivity terminals, including its u5 and u8 product lines, that switch between LEO and GEO networks for mobile land and maritime use.

Defense TechHardwareSpace TechRedmond, US

Marc Stolzman(Executive Officer)inBill Marks(Executive Officer)Keith Cochran(Executive Officer)inManny Mora(President and CEO)inAnne(Chief Financial Officer)inRyan(Chief Scientist)in

Co-investorsLux CapitalManta Ray VenturesOUP (Osage University Partners)Tectonic Ventures

San Diego, US

Bob Kain(Executive Officer, Director)inDawn Barry(Executive Officer)inJoseph C. Beery(Executive Officer, Director)

Co-investorsARCH Venture PartnersBain Capital VenturesF-Prime CapitalIllumina Ventures

BiotechKing Of Prussia, US

Brian MacDonald(Executive Officer, Director)Remy Sukhija(Executive Officer)

BoardJames Topper(Director)Markus Goebel(Director)Jeffrey Bird(Director)Colin Goddard(Director)

Co-investorsFrazier Healthcare PartnersFrazier Life SciencesNovartis Venture FundSutter Hill Ventures

Metalenz develops metasurface optics technology for optical sensing in consumer and industrial devices.

Deep TechHardwareSemiconductorsStoneham, US

Federico Capasso(Director)Rob Devlin(Founder)in

BoardXuhui Shao(Director)in

Co-investorsBantam GroupBraemar Energy VenturesFoothill VenturesGlobal BrainIntel CapitalM Ventures+7 more

Neuros Medical develops the Altius Direct Electrical Nerve Stimulation System, an FDA-approved implantable device that delivers patient-controlled electrical stimulation to treat chronic post-amputation pain in adult lower limb amputees.

BiotechHealthtechMedical DevicesAliso Viejo, US

David Veino(President and CEO)Zach Stassen(Chief Financial Officer)Robert J. Centa(Chief Financial Officer)Jon J. Snyder(Director, President, Secretary and CEO)in

BoardJoyce Erony(Director)inWilliam Harrington(Director)

Co-investorsAmzak HealthAPERTURE Venture PartnersCWRU Technology VenturesiSelect FundJobsOhio VenturesJumpstart Ventures+5 more

Boston, US

Jamil Beg(Executive Officer, Director)Elliot Ehrich(Director)

BoardAndrew Schwab(Director)

Co-investors5AMAbingworthBessemer Venture PartnersBioluminescence Ventures

Nocion Therapeutics develops small molecule charged sodium channel blockers (nocions) designed to silence overactive sensory nerves.

BiotechHealthtechMedical DevicesWatertown, US

MATTHEW FRANKEL(Executive Officer)inPETER COUROSSI(Executive Officer)RICHARD BATYCKY(Executive Officer, Director)JAMES ELLIS(Executive Officer)MICHAEL LIPP(Executive Officer)inCHRISTOPHER SILBER(Executive Officer)in

Co-investorsCanaan PartnersF-Prime CapitalMission BiocapitalMonograph Capital PartnersOUP (Osage University Partners)

Opsys develops solid-state scanning LiDAR sensors with no moving parts, using VCSEL and SPAD chip technology for autonomous driving and industrial applications.

AI & Machine LearningDeep TechHardwareRoboticsIsrael, IL

Co-investors83NorthOUP (Osage University Partners)Saban VenturesTransLink Capital

Picwell operates ALEX, a benefits decision-support platform that combines plan recommendations, enrollment, benefits administration, and year-round guidance for employees.

HR TechInsurTechSaaSPhiladelphia, US

Thomas Baker(Executive Officer, Director)Jonathan Thompson Kolstad(Executive Officer, Director)Robert James Town(Executive Officer, Director)Jay Silverstein(Executive Officer, Director)inAnirudh Vemprala(Executive Officer, Director)

BoardKevin Hill(Director)

Co-investorsBlue Venture FundsMassMutual VenturesOUP (Osage University Partners)

PMV Pharma develops precision oncology therapies that target and structurally correct mutated p53 proteins to restore their tumor-suppressing function.

BiotechHealthtechCranbury, US

David H. Mack, Ph.D.(Founder)inDavid Mack(Executive Officer, Director)Arnold Levine(Director)

BoardPeter Thompson(Director)Steve Winick(Director)Arnold Oronsky(Director)

Co-investorsAvoro Capital AdvisorsNextech InvestOUP (Osage University Partners)RA CapitalOrbiMed

Precede Biosciences develops a blood-based diagnostic platform that profiles gene expression from cell-free DNA to reveal disease biology at the transcriptional level for drug developers and clinical trials.

AI & Machine LearningBiotechDigital HealthBoston, US

Rehan Verjee(Co-Founder, Chief Executive Officer, Board Director)inSylvan Baca(Co-Founder; Assistant Professor of Medicine, Dana-Farber Cancer Institute)inToni Choueiri(Co-Founder; Director, Lank Center for GU Oncology, Dana-Farber Cancer Institute)Matthew Freedman(Co-Founder; Professor of Medicine, Dana-Farber Cancer Institute)

Co-investorsIllumina Ventures5AM VenturesOUP (Osage University Partners)Lilly Asia Ventures

Seismos provides an AI intelligence layer that converts acoustic signals and sensor measurements into real-time completion decisions for oil and gas well operators.

AI & Machine LearningDeep TechEnergyAustin, US

Panagiotis Adamopoulos(Executive Officer, Director)Panos Adamopoulos(Founder)inJeffrey Harris(Director)John Bain(Director)

BoardNoah Doyle(Director)in

Co-investorsEdison PartnersJavelin Venture Partners

Terremoto Biosciences is a clinical-stage biotech developing precision therapies for oncology and genetic diseases using lysine-targeted covalent chemistry.

BiotechDeep TechSouth San Francisco, US

Grace Lu(Executive Officer)James Christensen(Executive Officer, Director)Charles Baum(Executive Officer, Director)

BoardMichael Goller(Director)Reid Huber(Director)inPeter Thompson(Director)

Co-investorsEcoR1 CapitalOrbiMedRA CapitalNovo HoldingsThird Rock Ventures

Tessera Therapeutics develops Gene Writing, a genome engineering technology platform designed to make permanent alterations to the human genome for treating diseases.

BiotechDigital HealthMedical Devices

Geoff von Maltzahn(Founder)inJoseph Romanelli(CEO)

Co-investorsArtis VenturesFlagship PioneeringMarch Capital PartnersOMX VenturesSoftBank Vision FundSolari Capital+4 more

Tessera provides a multi-agent AI platform for enterprise system modernization, automating processes across ERP, CRM, HCM, and finance systems with governed execution.

AI & Machine LearningEnterprise SoftwareSaaS

Kabir Nagrecha(Chief Executive Officer)inMing Chang(Chief Operating Officer)inAnirudh Sriram(Chief Technology Officer)inPrakash Gupta(Chief Revenue Officer)in

Co-investorsAndreessen HorowitzFoundation CapitalMyriad Venture PartnersOUP (Osage University Partners)

BiotechSan Diego, US

Alain Baron(Executive Officer, Director)JeenJoo Kang(Director)Robert Tjian(Director)Marcus Boehm(Executive Officer)

BoardAndrew Schwab(Director)in

Co-investors5AM VenturesAvego BioScience CapitalNew Enterprise Associates (NEA)OUP (Osage University Partners)Sanofi VenturesThe Column Group+3 more

BiotechChicago, US

Rand Sutherland(Director)James Sullivan(Executive Officer, Director)in

BoardJonathan Silverstein(Director)inBernard Davitian(Director)Uya Chuluunbaatar(Director)Mona Ashiya(Director)in

Co-investorsPontifax Venture CapitalAvoro VenturesCasdin CapitalOrbiMed

FintechSan Francisco, US

Co-investorsTechstarsLightspeed Venture PartnersWalden Catalyst